Historical record - last NADAC effective date: 3/18/2020
Product Information
NYSTATIN-TRIAMCINOLONE CREAM is a generic product labeled by Crown Laboratories, priced at $0.4757 per GM under NDC 00316022360. Its NADAC has been published 108 times since Mar 14, 2018.
FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Nystatin and Triamcinolone Acetonide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Crown LaboratoriesNDC
00316022360
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
3/18/2020
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207730FDA Approved
12/26/2017
TE Code
AT
On Market Since
1/2/2018
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE CREAM has been published 108 times since Mar 14, 2018, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4757 per GM |
|---|---|
| All-time high | $1.6611 (Apr 11, 2018) |
| All-time low | $0.3093 (Aug 21, 2019) |
| Median price | $0.4981 |
| Average price | $0.6793 |
| Largest weekly change | +45.3% (May 22, 2019) |
| Weeks tracked | 108 |
| Tracking since | Mar 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-70.4%
Last surveyed Apr 1, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 60% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE CREAM?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE CREAM, manufactured by Crown Laboratories, is $0.4757 per GM (NDC 00316022360), effective Apr 1, 2020.
How has the price of NYSTATIN-TRIAMCINOLONE CREAM changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has declined 70.4%. It has been tracked across 108 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE CREAM?
Since Mar 14, 2018, the NADAC for NYSTATIN-TRIAMCINOLONE CREAM has ranged from a low of $0.3093 (Aug 21, 2019) to a high of $1.6611 (Apr 11, 2018), with a median of $0.4981 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE CREAM?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYSTATIN-TRIAMCINOLONE CREAM, is $0.1893 per GM — about 60% below NYSTATIN-TRIAMCINOLONE CREAM.
Who manufactures NYSTATIN-TRIAMCINOLONE CREAM?
NYSTATIN-TRIAMCINOLONE CREAM (NDC 00316022360) is labeled by Crown Laboratories, and CMS classifies it as a generic product.